– a novel GPR 40 / FFA 1-specific agonist shows a favorable safety profile and exerts anti-diabetic effects in type 2 diabetic animalsKatarzyna Bazydlo-Guzenda,Pawel Buda,Mikołaj Matloka,Mateusz Mach,Filip Stelmach,Radosław Dzida,Damian Smuga,Joanna Hucz-Kalitowska, Malgorzata Teska-Kaminska, Varvara, Vialichka,Krzysztof Dubiel, Bozena Kaminska,Maciej Wieczoreksemanticscholar（2021）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
